The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Menomune-A & C & Y & W-135-Global Market Insights and Sales Trends 2024
Synopsis
Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
The global Menomune-A & C & Y & W-135 market size is expected to reach US$ 1802.2 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Menomune-A & C & Y & W-135 in various end use industries. The expanding demands from the Public and Private, are propelling Menomune-A & C & Y & W-135 market. Oligosaccharide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polysaccharide segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Menomune-A & C & Y & W-135, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Menomune-A & C & Y & W-135 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Menomune-A & C & Y & W-135 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Menomune-A & C & Y & W-135 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Menomune-A & C & Y & W-135 covered in this report include Sanofi Pasteur, GSK, Hualan Bio, Beijing Luzhu Biopharmaceutical, Walvax and Kanghua Bio, etc.
The global Menomune-A & C & Y & W-135 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
GSK
Hualan Bio
Beijing Luzhu Biopharmaceutical
Walvax
Kanghua Bio
Global Menomune-A & C & Y & W-135 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Menomune-A & C & Y & W-135 market, Segment by Type:
Oligosaccharide
Polysaccharide
Global Menomune-A & C & Y & W-135 market, by Application
Public
Private
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Menomune-A & C & Y & W-135 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Menomune-A & C & Y & W-135 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
The global Menomune-A & C & Y & W-135 market size is expected to reach US$ 1802.2 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Menomune-A & C & Y & W-135 in various end use industries. The expanding demands from the Public and Private, are propelling Menomune-A & C & Y & W-135 market. Oligosaccharide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polysaccharide segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Menomune-A & C & Y & W-135, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Menomune-A & C & Y & W-135 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Menomune-A & C & Y & W-135 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Menomune-A & C & Y & W-135 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Menomune-A & C & Y & W-135 covered in this report include Sanofi Pasteur, GSK, Hualan Bio, Beijing Luzhu Biopharmaceutical, Walvax and Kanghua Bio, etc.
The global Menomune-A & C & Y & W-135 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
GSK
Hualan Bio
Beijing Luzhu Biopharmaceutical
Walvax
Kanghua Bio
Global Menomune-A & C & Y & W-135 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Menomune-A & C & Y & W-135 market, Segment by Type:
Oligosaccharide
Polysaccharide
Global Menomune-A & C & Y & W-135 market, by Application
Public
Private
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Menomune-A & C & Y & W-135 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Menomune-A & C & Y & W-135 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Menomune-A & C & Y & W-135 Market Overview
1.1 Menomune-A & C & Y & W-135 Product Overview
1.2 Menomune-A & C & Y & W-135 Market Segment by Type
1.2.1 Oligosaccharide
1.2.2 Polysaccharide
1.3 Global Menomune-A & C & Y & W-135 Market Size by Type
1.3.1 Global Menomune-A & C & Y & W-135 Market Size Overview by Type (2018-2029)
1.3.2 Global Menomune-A & C & Y & W-135 Historic Market Size Review by Type (2018-2023)
1.3.3 Global Menomune-A & C & Y & W-135 Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Menomune-A & C & Y & W-135 Sales Breakdown by Type (2018-2023)
1.4.2 Europe Menomune-A & C & Y & W-135 Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Menomune-A & C & Y & W-135 Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Menomune-A & C & Y & W-135 Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Menomune-A & C & Y & W-135 Sales Breakdown by Type (2018-2023)
2 Global Menomune-A & C & Y & W-135 Market Competition by Company
2.1 Global Top Players by Menomune-A & C & Y & W-135 Sales (2018-2023)
2.2 Global Top Players by Menomune-A & C & Y & W-135 Revenue (2018-2023)
2.3 Global Top Players by Menomune-A & C & Y & W-135 Price (2018-2023)
2.4 Global Top Manufacturers Menomune-A & C & Y & W-135 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Menomune-A & C & Y & W-135 Market Competitive Situation and Trends
2.5.1 Menomune-A & C & Y & W-135 Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Menomune-A & C & Y & W-135 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Menomune-A & C & Y & W-135 as of 2022)
2.7 Date of Key Manufacturers Enter into Menomune-A & C & Y & W-135 Market
2.8 Key Manufacturers Menomune-A & C & Y & W-135 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Menomune-A & C & Y & W-135 Status and Outlook by Region
3.1 Global Menomune-A & C & Y & W-135 Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Menomune-A & C & Y & W-135 Historic Market Size by Region
3.2.1 Global Menomune-A & C & Y & W-135 Sales in Volume by Region (2018-2023)
3.2.2 Global Menomune-A & C & Y & W-135 Sales in Value by Region (2018-2023)
3.2.3 Global Menomune-A & C & Y & W-135 Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Menomune-A & C & Y & W-135 Forecasted Market Size by Region
3.3.1 Global Menomune-A & C & Y & W-135 Sales in Volume by Region (2024-2029)
3.3.2 Global Menomune-A & C & Y & W-135 Sales in Value by Region (2024-2029)
3.3.3 Global Menomune-A & C & Y & W-135 Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Menomune-A & C & Y & W-135 by Application
4.1 Menomune-A & C & Y & W-135 Market Segment by Application
4.1.1 Public
4.1.2 Private
4.2 Global Menomune-A & C & Y & W-135 Market Size by Application
4.2.1 Global Menomune-A & C & Y & W-135 Market Size Overview by Application (2018-2029)
4.2.2 Global Menomune-A & C & Y & W-135 Historic Market Size Review by Application (2018-2023)
4.2.3 Global Menomune-A & C & Y & W-135 Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Menomune-A & C & Y & W-135 Sales Breakdown by Application (2018-2023)
4.3.2 Europe Menomune-A & C & Y & W-135 Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Menomune-A & C & Y & W-135 Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Menomune-A & C & Y & W-135 Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Menomune-A & C & Y & W-135 Sales Breakdown by Application (2018-2023)
5 North America Menomune-A & C & Y & W-135 by Country
5.1 North America Menomune-A & C & Y & W-135 Historic Market Size by Country
5.1.1 North America Menomune-A & C & Y & W-135 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Menomune-A & C & Y & W-135 Sales in Volume by Country (2018-2023)
5.1.3 North America Menomune-A & C & Y & W-135 Sales in Value by Country (2018-2023)
5.2 North America Menomune-A & C & Y & W-135 Forecasted Market Size by Country
5.2.1 North America Menomune-A & C & Y & W-135 Sales in Volume by Country (2024-2029)
5.2.2 North America Menomune-A & C & Y & W-135 Sales in Value by Country (2024-2029)
6 Europe Menomune-A & C & Y & W-135 by Country
6.1 Europe Menomune-A & C & Y & W-135 Historic Market Size by Country
6.1.1 Europe Menomune-A & C & Y & W-135 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Menomune-A & C & Y & W-135 Sales in Volume by Country (2018-2023)
6.1.3 Europe Menomune-A & C & Y & W-135 Sales in Value by Country (2018-2023)
6.2 Europe Menomune-A & C & Y & W-135 Forecasted Market Size by Country
6.2.1 Europe Menomune-A & C & Y & W-135 Sales in Volume by Country (2024-2029)
6.2.2 Europe Menomune-A & C & Y & W-135 Sales in Value by Country (2024-2029)
7 Asia-Pacific Menomune-A & C & Y & W-135 by Region
7.1 Asia-Pacific Menomune-A & C & Y & W-135 Historic Market Size by Region
7.1.1 Asia-Pacific Menomune-A & C & Y & W-135 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Menomune-A & C & Y & W-135 Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Menomune-A & C & Y & W-135 Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Menomune-A & C & Y & W-135 Forecasted Market Size by Region
7.2.1 Asia-Pacific Menomune-A & C & Y & W-135 Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Menomune-A & C & Y & W-135 Sales in Value by Region (2024-2029)
8 Latin America Menomune-A & C & Y & W-135 by Country
8.1 Latin America Menomune-A & C & Y & W-135 Historic Market Size by Country
8.1.1 Latin America Menomune-A & C & Y & W-135 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Menomune-A & C & Y & W-135 Sales in Volume by Country (2018-2023)
8.1.3 Latin America Menomune-A & C & Y & W-135 Sales in Value by Country (2018-2023)
8.2 Latin America Menomune-A & C & Y & W-135 Forecasted Market Size by Country
8.2.1 Latin America Menomune-A & C & Y & W-135 Sales in Volume by Country (2024-2029)
8.2.2 Latin America Menomune-A & C & Y & W-135 Sales in Value by Country (2024-2029)
9 Middle East and Africa Menomune-A & C & Y & W-135 by Country
9.1 Middle East and Africa Menomune-A & C & Y & W-135 Historic Market Size by Country
9.1.1 Middle East and Africa Menomune-A & C & Y & W-135 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Menomune-A & C & Y & W-135 Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Menomune-A & C & Y & W-135 Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Menomune-A & C & Y & W-135 Forecasted Market Size by Country
9.2.1 Middle East and Africa Menomune-A & C & Y & W-135 Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Menomune-A & C & Y & W-135 Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Pasteur Menomune-A & C & Y & W-135 Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Menomune-A & C & Y & W-135 Products Offered
10.2.5 GSK Recent Development
10.3 Hualan Bio
10.3.1 Hualan Bio Company Information
10.3.2 Hualan Bio Introduction and Business Overview
10.3.3 Hualan Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Hualan Bio Menomune-A & C & Y & W-135 Products Offered
10.3.5 Hualan Bio Recent Development
10.4 Beijing Luzhu Biopharmaceutical
10.4.1 Beijing Luzhu Biopharmaceutical Company Information
10.4.2 Beijing Luzhu Biopharmaceutical Introduction and Business Overview
10.4.3 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Products Offered
10.4.5 Beijing Luzhu Biopharmaceutical Recent Development
10.5 Walvax
10.5.1 Walvax Company Information
10.5.2 Walvax Introduction and Business Overview
10.5.3 Walvax Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Walvax Menomune-A & C & Y & W-135 Products Offered
10.5.5 Walvax Recent Development
10.6 Kanghua Bio
10.6.1 Kanghua Bio Company Information
10.6.2 Kanghua Bio Introduction and Business Overview
10.6.3 Kanghua Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kanghua Bio Menomune-A & C & Y & W-135 Products Offered
10.6.5 Kanghua Bio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Menomune-A & C & Y & W-135 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Menomune-A & C & Y & W-135 Industrial Chain Analysis
11.4 Menomune-A & C & Y & W-135 Market Dynamics
11.4.1 Menomune-A & C & Y & W-135 Industry Trends
11.4.2 Menomune-A & C & Y & W-135 Market Drivers
11.4.3 Menomune-A & C & Y & W-135 Market Challenges
11.4.4 Menomune-A & C & Y & W-135 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Menomune-A & C & Y & W-135 Distributors
12.3 Menomune-A & C & Y & W-135 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
